Health CareMedical Equipment and Services
  • Price (USD)235.68
  • Today's Change-2.22 / -0.93%
  • Shares traded219.74k
  • 1 Year change-7.36%
  • Beta0.9820
Data delayed at least 15 minutes, as of Dec 06 2022 15:20 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Stryker Corporation (Stryker) is a medical technology company. The Company offers products and services in Medical and Surgical, Neurotechnology, Orthopaedics, and Spine that help improve patient and hospital outcomes. Its products are sold in approximately 75 countries through Company-owned subsidiaries and branches, as well as, third-party dealers and distributors. Its products include surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment and intensive care disposable products; neurosurgical and neurovascular devices; implants used in joint replacement and trauma surgeries; Mako Robotic-Arm Assisted technology; spinal devices; as well as other products used in a range of medical specialties. Its business segments include MedSurg and Neurotechnology and Orthopaedics and Spine. Its subsidiaries include Alcott Indemnity Company, Arrinex, Inc., Berchtold Corporation, and BioMimetic Therapeutics, LLC.

  • Revenue in USD (TTM)17.95bn
  • Net income in USD2.46bn
  • Incorporated1946
  • Employees46.00k
  • Location
    Stryker Corp2825 Airview BlvdKALAMAZOO 49002United StatesUSA
  • Phone+1 (269) 389-2600
  • Fax+1 (269) 385-1062
  • Websitehttps://www.stryker.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SYK:NYQ since
Vocera Communications IncDeal completed06 Jan 202206 Jan 2022Deal completed-13.43%2.97bn
Data delayed at least 15 minutes, as of Dec 06 2022 15:20 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
DexCom, Inc.2.79bn230.00m45.02bn6.30k217.7224.67117.9516.120.53540.53546.714.720.57732.875.11443,301.604.755.565.726.5065.9767.298.248.913.4312.920.52660.0027.0833.69-68.66--47.52--
Edwards Lifesciences Corp5.36bn1.46bn45.66bn15.70k31.797.3628.618.512.322.328.5410.040.63861.518.80341,643.3017.3715.9919.5618.9578.9375.1127.2023.633.00--0.08750.0019.2912.0482.5521.428.69--
Boston Scientific Corporation12.57bn597.00m65.06bn41.00k109.433.6937.635.180.41510.41518.7412.320.39382.317.10306,512.
Becton Dickinson and Co18.87bn1.55bn69.77bn77.00k45.792.7618.493.705.385.8865.7289.220.35343.418.05245,064.903.062.213.542.5144.9245.788.666.550.62956.580.388586.56-1.369.312.058.456.00--
Stryker Corporation17.95bn2.46bn90.02bn46.00k37.005.4726.175.026.436.4346.9543.510.51191.776.06390,173.907.016.738.047.9563.9565.5713.6913.161.19--0.436642.3919.218.6024.703.901.3911.20
Intuitive Surgical, Inc.6.12bn1.38bn95.31bn9.79k71.438.2854.2115.583.783.7816.7732.590.46712.777.92624,721.8010.6214.1211.6715.6867.7768.8322.7329.384.42--0.000.0031.0116.1060.7218.2245.67--
Medtronic PLC30.81bn4.32bn104.80bn95.00k24.472.0214.883.403.223.2223.0139.000.33312.125.54324,294.804.705.085.355.7267.6268.4614.1015.451.4119.750.338362.615.211.3043.974.581.767.94
Data as of Dec 06 2022. Currency figures normalised to Stryker Corp's reporting currency: US Dollar USD

Institutional shareholders

38.51%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 30 Sep 202228.40m7.51%
T. Rowe Price Associates, Inc. (Investment Management)as of 30 Sep 202220.13m5.32%
Greenleaf Asset Management, Inc.as of 30 Sep 202219.81m5.24%
Wellington Management Co. LLPas of 30 Sep 202217.65m4.67%
BlackRock Fund Advisorsas of 30 Sep 202215.62m4.13%
SSgA Funds Management, Inc.as of 30 Sep 202214.05m3.71%
Capital Research & Management Co. (Global Investors)as of 30 Sep 202212.63m3.34%
Fundsmith LLPas of 30 Sep 20227.26m1.92%
Geode Capital Management LLCas of 30 Sep 20225.70m1.51%
Franklin Advisers, Inc.as of 30 Sep 20224.42m1.17%
More ▼
Data from 30 Sep 2022 - 30 Sep 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.